Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 416

1.

Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma.

Zhuang L, Lee CS, Scolyer RA, McCarthy SW, Zhang XD, Thompson JF, Hersey P.

Mod Pathol. 2007 Apr;20(4):416-26.

2.

Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins.

Zhuang L, Scolyer RA, Murali R, McCarthy SW, Zhang XD, Thompson JF, Hersey P.

Mod Pathol. 2010 Jan;23(1):45-53. doi: 10.1038/modpathol.2009.129. Epub 2009 Oct 16.

3.

Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.

Nazarian RM, Prieto VG, Elder DE, Duncan LM.

J Cutan Pathol. 2010 Apr;37 Suppl 1:41-7. doi: 10.1111/j.1600-0560.2010.01505.x.

PMID:
20482674
4.

Expression of phosphorylated Stat3, cyclin D1 and Bcl-xL in extramammary Paget disease.

Liu HJ, Moroi Y, Masuda T, Yasumoto S, Kokuba H, Imafuku S, Koga T, Tetsuya T, Tu YT, Aburatani H, Furue M, Urabe K.

Br J Dermatol. 2006 May;154(5):926-32.

PMID:
16634897
5.

Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma.

Leiter U, Schmid RM, Kaskel P, Peter RU, Krähn G.

Arch Dermatol Res. 2000 May;292(5):225-32.

PMID:
10867810
6.

Expression of apoptosis regulators in cutaneous malignant melanoma.

Tang L, Tron VA, Reed JC, Mah KJ, Krajewska M, Li G, Zhou X, Ho VC, Trotter MJ.

Clin Cancer Res. 1998 Aug;4(8):1865-71.

7.

STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation.

Lassmann S, Schuster I, Walch A, Göbel H, Jütting U, Makowiec F, Hopt U, Werner M.

J Clin Pathol. 2007 Feb;60(2):173-9.

8.

Expression of CD40, CD44, bcl-2 antigens and rate of cell proliferation on fine needle aspirates from metastatic melanoma.

Sviatoha V, Rundgren A, Tani E, Hansson J, Kleina R, Skoog L.

Cytopathology. 2002 Feb;13(1):11-21.

PMID:
11985564
9.

Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma.

Salti GI, Manougian T, Farolan M, Shilkaitis A, Majumdar D, Das Gupta TK.

Cancer Res. 2000 Sep 15;60(18):5012-6.

10.

Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma.

Sánchez-Ceja SG, Reyes-Maldonado E, Vázquez-Manríquez ME, López-Luna JJ, Belmont A, Gutiérrez-Castellanos S.

Lung Cancer. 2006 Nov;54(2):163-8. Epub 2006 Sep 7.

PMID:
16959370
11.

Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines.

Selzer E, Schlagbauer-Wadl H, Okamoto I, Pehamberger H, Pötter R, Jansen B.

Melanoma Res. 1998 Jun;8(3):197-203.

PMID:
9664140
12.

Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma.

Prieto VG, Mourad-Zeidan AA, Melnikova V, Johnson MM, Lopez A, Diwan AH, Lazar AJ, Shen SS, Zhang PS, Reed JA, Gershenwald JE, Raz A, Bar-Eli M.

Clin Cancer Res. 2006 Nov 15;12(22):6709-15.

13.

LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma.

Long E, Ilie M, Hofman V, Havet K, Selva E, Butori C, Lacour JP, Nelson AM, Cathomas G, Hofman P.

Virchows Arch. 2009 Aug;455(2):159-70. doi: 10.1007/s00428-009-0791-1. Epub 2009 May 30.

PMID:
19484260
14.

Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma.

Zhuang L, Scolyer RA, Lee CS, McCarthy SW, Cooper WA, Zhang XD, Thompson JF, Hersey P.

Histopathology. 2009 Mar;54(4):462-70. doi: 10.1111/j.1365-2559.2009.03242.x.

PMID:
19309398
15.

bcl-2 protein expression in melanocytic neoplasms of the skin.

Ramsay JA, From L, Kahn HJ.

Mod Pathol. 1995 Feb;8(2):150-4.

PMID:
7777475
16.

Predictive value of cyclooxygenase 2 and Bcl-2 for cervical lymph node metastasis in mucoepidermoid carcinoma.

Zyada MM, Grawish ME, Elsabaa HM.

Ann Diagn Pathol. 2009 Oct;13(5):313-21. doi: 10.1016/j.anndiagpath.2009.06.003. Epub 2009 Aug 14.

PMID:
19751908
17.

Idiosyncrasies of scalp melanoma.

Rigual NR, Cheney RT, Iwenofu OH, Li Q, Loree TR, Popat SR, Merzianu M.

Laryngoscope. 2007 Aug;117(8):1354-8.

PMID:
17592396
18.

Bcl-xL and bcl-2 proteins in melanoma progression and UVB-induced apoptosis.

Zhang H, Rosdahl I.

Int J Oncol. 2006 Mar;28(3):661-6.

PMID:
16465371
19.

Myeloid leukemia-1 expression in benign and malignant melanocytic lesions.

Wong RP, Khosravi S, Martinka M, Li G.

Oncol Rep. 2008 Apr;19(4):933-7.

PMID:
18357378
20.

Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi.

Holt JB, Sangueza OP, Levine EA, Shen P, Bergman S, Geisinger KR, Creager AJ.

Am J Clin Pathol. 2004 Jan;121(1):58-63.

PMID:
14750241

Supplemental Content

Support Center